Taysha Gene Therapies, Inc. (TSHA) shares outstanding

Shares outstanding · fiscal 2025
319.71M

Taysha Gene Therapies, Inc. (TSHA) had 319.71M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 27.8% higher than the 250.13M of fiscal 2024. Figures as of 18 Nov 2026, 11:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
319.71M
Change on fiscal 2024
+27.8%
Highest on record
319.71Mfiscal 2025
Lowest on record
37.65Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Taysha Gene Therapies, Inc. shares outstanding, in more detail

The market data feed counts 326.05M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 319.71M in fiscal 2025 and the lowest 37.65M in fiscal 2021.

History · 5 fiscal years

Shares outstanding by fiscal year

Taysha Gene Therapies, Inc. shares outstanding, year by year

Taysha Gene Therapies, Inc. (TSHA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025319.71M 27.8% up
2024250.13M 115.4% up
2023116.12M 164.2% up
202243.95M 16.7% up
202137.65M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on TSHA

Taysha Gene Therapies, Inc., figure by figure

Taysha Gene Therapies, Inc. (TSHA) overview: price, valuation and scorecard

Taysha Gene Therapies, Inc. shares outstanding: questions and answers

How many shares does Taysha Gene Therapies, Inc. have?

Taysha Gene Therapies, Inc. (TSHA) had 319.71M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 27.8% higher than the 250.13M of fiscal 2024. The market data feed counts 326.05M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Taysha Gene Therapies, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 319.71M in fiscal 2025 and the lowest 37.65M in fiscal 2021.

How is Taysha Gene Therapies, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Taysha Gene Therapies, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Taysha Gene Therapies, Inc. (TSHA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TSHA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.